Reuters logo
BRIEF-CTI Biopharma announces pricing of underwritten public offering of $45 mln of convertible preferred stock
June 6, 2017 / 1:16 PM / in 4 months

BRIEF-CTI Biopharma announces pricing of underwritten public offering of $45 mln of convertible preferred stock

June 6 (Reuters) - CTI Biopharma Corp

* CTI Biopharma prices underwritten public offering of $45 million of convertible preferred stock

* CTI Biopharma-prices underwritten public offering of 22,500 shares of series n-3 preferred stock, offered at price to public of $2,000 per share of series n-3 preferred stock Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below